The Journal of Immunology, Vol 157, Issue 7 2953-2960, Copyright © 1996 by American Association of Immunologists

ARTICLES

The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential. Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta

OP Veiby, FW Jacobsen, L Cui, SD Lyman and SE Jacobsen
Hipple Cancer Research Center, Dayton, OH 45439, USA.

The recently cloned fIt3 ligand (FL) potently enhances hemopoietic growth factor-induced growth of primitive hemopoietic progenitors. In agreement with previous reports, we found FL alone to be a weak mitogen for primitive Lin-Sca-1+ murine bone marrow progenitors. Using delayed addition of growth-promoting cytokines, we demonstrate that FL potently promotes the in vitro survival of Lin-Sca-1+ progenitors responsive to a potent myeloid growth factor combination (FL, stem cell factor (SCF), granulocyte CSF (G-CSF), and IL-1 alpha). Whereas no such progenitors survived in cultures supplemented with medium alone, 33% survived in FL compared with 75 and 13% in the presence of SCF and IL-1 alpha, respectively. These results were obtained when cells were plated individually, suggesting that the viability-promoting effect of FL is mediated directly on the progenitors. Whereas SCF was superior to FL in promoting the survival of FL-, SCF-, G-CSF-, and IL-1 alpha-stimulated Lin-Sca-1+ progenitors, FL was more efficient than SCF at promoting the survival of progenitors with a B cell potential, as measured by their ability to produce B220+ cells in response to delayed addition of FL, SCF, and IL-7. Seventy-one percent of the B220+ cell production could be recovered following 40-h incubation with FL compared with 2% in response to SCF. Analysis of day 12 spleen CFU content after 40-h preincubation of Lin-Sca-1+ cells in FL or SCF demonstrated that SCF maintained 64% of the day 12 spleen CFU, whereas only 16% survived in the presence of FL. Finally, there was no significant difference between the ability of FL and SCF to maintain the viability of long- term culture-initiating cells (25 and 32%, respectively). The ability of FL to promote the survival of Lin-Sca-1+ progenitor cells was reflected by the finding that FL also suppressed apoptosis. Finally, TGF-beta abrogated and TNF-alpha potently counteracted the survival- promoting effect of FL. Thus, FL promotes the survival of primitive hemopoietic progenitor cells, in particular those with an inherent B lymphoid potential.

This article has been cited by other articles:

				E. Carreras, S. Turner, V. Paharkova-Vatchkova, A. Mao, C. Dascher, and S. Kovats Estradiol Acts Directly on Bone Marrow Myeloid Progenitors to Differentially Regulate GM-CSF or Flt3 Ligand-Mediated Dendritic Cell Differentiation J. Immunol., January 15, 2008; 180(2): 727 - 738. [Abstract] [Full Text] [PDF]

				R. Karlsson, M. Engstrom, M. Jonsson, P. Karlberg, C. J.H. Pronk, J. Richter, and J.-I. Jonsson Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes J. Leukoc. Biol., November 1, 2003; 74(5): 923 - 931. [Abstract] [Full Text] [PDF]

				M. Krampera, S. Glennie, J. Dyson, D. Scott, R. Laylor, E. Simpson, and F. Dazzi Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide Blood, May 1, 2003; 101(9): 3722 - 3729. [Abstract] [Full Text] [PDF]

				G. Miller, V. G. Pillarisetty, A. B. Shah, S. Lahrs, and R. P. DeMatteo Murine Flt3 Ligand Expands Distinct Dendritic Cells with Both Tolerogenic and Immunogenic Properties J. Immunol., April 1, 2003; 170(7): 3554 - 3564. [Abstract] [Full Text] [PDF]

				X. Fan, G. Valdimarsdottir, J. Larsson, A. Brun, M. Magnusson, S. E. Jacobsen, P. ten Dijke, and S. Karlsson Transient Disruption of Autocrine TGF-{beta} Signaling Leads to Enhanced Survival and Proliferation Potential in Single Primitive Human Hemopoietic Progenitor Cells J. Immunol., January 15, 2002; 168(2): 755 - 762. [Abstract] [Full Text] [PDF]

				T. Matsushima, M. Nakashima, K. Oshima, Y. Abe, J. Nishimura, H. Nawata, T. Watanabe, and K. Muta Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells Blood, July 15, 2001; 98(2): 313 - 321. [Abstract] [Full Text] [PDF]

				M. Mizuki, R. Fenski, H. Halfter, I. Matsumura, R. Schmidt, C. Muller, W. Gruning, K. Kratz-Albers, S. Serve, C. Steur, et al. Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways Blood, December 1, 2000; 96(12): 3907 - 3914. [Abstract] [Full Text] [PDF]

				N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis Blood, September 15, 2000; 96(6): 2022 - 2036. [Abstract] [Full Text] [PDF]

				S. Zhang, S. Fukuda, Y. Lee, G. Hangoc, S. Cooper, R. Spolski, W. J. Leonard, and H. E. Broxmeyer Essential Role of Signal Transducer and Activator of Transcription (Stat)5a but Not Stat5b for Flt3-Dependent Signaling J. Exp. Med., September 5, 2000; 192(5): 719 - 728. [Abstract] [Full Text] [PDF]

				H. Nagaoka, G. Gonzalez-Aseguinolaza, M. Tsuji, and M. C. Nussenzweig Immunization and Infection Change the Number of Recombination Activating Gene (Rag)-Expressing B Cells in the Periphery by Altering Immature Lymphocyte Production J. Exp. Med., June 19, 2000; 191(12): 2113 - 2120. [Abstract] [Full Text] [PDF]

				M. Rosenzwajg, L. Tailleux, and J. C. Gluckman CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34+ cells Blood, January 15, 2000; 95(2): 453 - 460. [Abstract] [Full Text] [PDF]

				P Batard, M. Monier, N Fortunel, K Ducos, P Sansilvestri-Morel, T Phan, A Hatzfeld, and J. Hatzfeld TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation J. Cell Sci., January 2, 2000; 113(3): 383 - 390. [Abstract] [PDF]

				A. Bennaceur-Griscelli, C. Tourino, B. Izac, W. Vainchenker, and L. Coulombel Murine Stromal Cells Counteract the Loss of Long-Term Culture-Initiating Cell Potential Induced by Cytokines in CD34+CD38low/neg Human Bone Marrow Cells Blood, July 15, 1999; 94(2): 529 - 538. [Abstract] [Full Text] [PDF]

				R. G. Wickremasinghe and A. V. Hoffbrand Biochemical and Genetic Control of Apoptosis: Relevance to Normal Hematopoiesis and Hematological Malignancies Blood, June 1, 1999; 93(11): 3587 - 3600. [Full Text] [PDF]

				J. S. Miller, V. McCullar, M. Punzel, I. R. Lemischka, and K. A. Moore Single Adult Human CD34+/Lin-/CD38- Progenitors Give Rise to Natural Killer Cells, B-Lineage Cells, Dendritic Cells, and Myeloid Cells Blood, January 1, 1999; 93(1): 96 - 106. [Abstract] [Full Text] [PDF]

				T. S. Hawley, A. Z.C. Fong, H. Griesser, S. D. Lyman, and R. G. Hawley Leukemic Predisposition of Mice Transplanted With Gene-Modified Hematopoietic Precursors Expressing flt3 Ligand Blood, September 15, 1998; 92(6): 2003 - 2011. [Abstract] [Full Text] [PDF]

				U. Kapp, M. Bhatia, D. Bonnet, B. Murdoch, and J. E. Dick Treatment of Non-Obese Diabetic (NOD)/Severe-Combined Immunodeficient Mice (SCID) With flt3 Ligand and Interleukin-7 Impairs the B-Lineage Commitment of Repopulating Cells After Transplantation of Human Hematopoietic Cells Blood, September 15, 1998; 92(6): 2024 - 2031. [Abstract] [Full Text] [PDF]

				A. Gratwohl, L. John, H. Baldomero, J. Roth, A. Tichelli, C. Nissen, S.D. Lyman, and A. Wodnar-Filipowicz FLT-3 Ligand Provides Hematopoietic Protection From Total Body Irradiation in Rabbits Blood, August 1, 1998; 92(3): 765 - 769. [Abstract] [Full Text] [PDF]

				T. Matsunaga, T. Kato, H. Miyazaki, and M. Ogawa Thrombopoietin Promotes the Survival of Murine Hematopoietic Long-Term Reconstituting Cells: Comparison With the Effects of FLT3/FLK-2 Ligand and Interleukin-6 Blood, July 15, 1998; 92(2): 452 - 461. [Abstract] [Full Text] [PDF]

				S. D. Lyman and S. E. W. Jacobsen c-kit Ligand and Flt3 Ligand: Stem/Progenitor Cell Factors With Overlapping Yet Distinct Activities Blood, February 15, 1998; 91(4): 1101 - 1134. [Full Text] [PDF]

				J. M. Francis, C. M. Heyworth, E. Spooncer, A. Pierce, T. M. Dexter, and A. D. Whetton Transforming Growth Factor-beta 1 Induces Apoptosis Independently of p53 and Selectively Reduces Expression of Bcl-2 in Multipotent Hematopoietic Cells J. Biol. Chem., December 8, 2000; 275(50): 39137 - 39145. [Abstract] [Full Text] [PDF]